440
Views
0
CrossRef citations to date
0
Altmetric
Special Feature

CEE-ing is believing

Bioscience ventures in Central and Eastern Europe

Pages 3031-3035 | Received 28 Jul 2011, Accepted 29 Jul 2011, Published online: 15 Sep 2011
 

Abstract

Bioscience ventures in Central and Eastern Europe are becoming a presence in world healthcare markets despite a perennially short supply of venture funding and other support mechanisms relative to other world economic regions. Here are three up-and-coming CEE stories worth keeping an eye on.

Conflict of Interest

Landes Bioscience owns equity in MedicAlgorithmics and ImmunoGenes.